{
  "id": "NCLEX_NGN_CLOZE_2026_001",
  "questionType": "clozeDropdown",
  "stem": "A nurse in the emergency department is caring for a 78-year-old male with a history of Stage 3 Chronic Kidney Disease (CKD) and Heart Failure with Preserved Ejection Fraction (HFpEF). The client presented with palpitations and shortness of breath. The provider has diagnosed atrial fibrillation with rapid ventricular response (RVR) and placed new orders. The nurse reviews the client’s electronic health record prior to administering medications.\n\nThe nurse’s priority is to **[1]** and then **[2]**.",
  "tabs": [
    {
      "title": "Nurses' Notes",
      "content": "**1400:** Client arrived via private vehicle, accompanied by daughter. Reports sudden onset of “heart racing” and feeling “lightheaded” for the past 2 hours. Daughter states he has been more fatigued recently and has not been checking his blood sugar due to a broken glucometer. Client is alert and oriented x4, anxious.\n\n**1515:** Client now appears pale and lethargic. Skin is cool and clammy to the touch. Responds to verbal stimuli but slow to answer questions. Reports worsening shortness of breath."
    },
    {
      "title": "Vital Signs",
      "content": [
        {
          "label": "Time",
          "values": [
            "1405 (Arrival)",
            "1510 (Current)"
          ]
        },
        {
          "label": "Heart Rate (bpm)",
          "values": [
            "158",
            "166"
          ]
        },
        {
          "label": "Blood Pressure",
          "values": [
            "112/74",
            "84/52"
          ]
        },
        {
          "label": "Respiratory Rate (breaths/min)",
          "values": [
            "22",
            "28"
          ]
        },
        {
          "label": "SpO2",
          "values": [
            "94% on room air",
            "91% on 2L NC"
          ]
        },
        {
          "label": "Temperature",
          "values": [
            "37.1°C (98.8°F)",
            "37.0°C (98.6°F)"
          ]
        }
      ]
    },
    {
      "title": "Laboratory Results",
      "content": [
        {
          "label": "Potassium",
          "value": "6.9 mEq/L",
          "range": "3.5-5.0 mEq/L",
          "isCritical": true
        },
        {
          "label": "BUN",
          "value": "52 mg/dL",
          "range": "10-20 mg/dL"
        },
        {
          "label": "Creatinine",
          "value": "3.1 mg/dL",
          "range": "0.6-1.2 mg/dL"
        },
        {
          "label": "Troponin I",
          "value": "0.18 ng/mL",
          "range": "<0.04 ng/mL"
        },
        {
          "label": "Lactate",
          "value": "4.5 mmol/L",
          "range": "0.5-2.2 mmol/L"
        }
      ]
    },
    {
      "title": "Provider's Orders",
      "content": "- Diltiazem 15 mg IV push over 2 minutes\n- Start Heparin infusion per hospital protocol\n- STAT Portable Chest X-ray\n- Place two large-bore peripheral IVs\n- Consult Cardiology"
    }
  ],
  "choices": {
    "1": [
      "withhold the diltiazem administration",
      "administer the diltiazem as prescribed",
      "request an order for an IV fluid bolus",
      "start the heparin infusion immediately"
    ],
    "2": [
      "notify the provider of the critical findings",
      "prepare the client for synchronized cardioversion",
      "increase oxygen to 6L via simple face mask",
      "administer prescribed IV furosemide"
    ]
  },
  "correctAnswer": [
    "withhold the diltiazem administration",
    "notify the provider of the critical findings"
  ],
  "rationale": {
    "correct": "The client is exhibiting signs of decompensated atrial fibrillation with rapid ventricular response (RVR) and possible cardiogenic shock, evidenced by hypotension (84/52 mmHg), elevated lactate (4.5 mmol/L), and cool, clammy skin. The critical hyperkalemia (6.9 mEq/L) further complicates the situation, posing a significant risk for life-threatening arrhythmias. Diltiazem, a calcium channel blocker, has negative inotropic and chronotropic effects, which would further decrease cardiac output and blood pressure in a patient already experiencing hemodynamic instability. This could lead to cardiovascular collapse. Therefore, the priority is to withhold the diltiazem. Following this critical safety measure, the nurse must immediately notify the provider of the client's deteriorating condition and critical lab values. This communication will facilitate prompt intervention to address the hyperkalemia (e.g., calcium gluconate, insulin/dextrose, sodium polystyrene sulfonate) and manage the atrial fibrillation, potentially with synchronized cardioversion after addressing the electrolyte imbalance. The SBAR communication should include the client's history (CKD, HFpEF), current presentation (palpitations, shortness of breath, lethargy), vital signs (HR 166 bpm, BP 84/52 mmHg, RR 28 breaths/min, SpO2 91% on 2L NC), and critical lab values (Potassium 6.9 mEq/L, Lactate 4.5 mmol/L).",
    "answerBreakdown": [
      {
        "label": "1",
        "choices": [
          {
            "content": "withhold the diltiazem administration",
            "isCorrect": true,
            "justification": "Correct. The client's hypotension (BP 84/52 mmHg) and signs of hypoperfusion (elevated lactate, cool/clammy skin) indicate potential cardiogenic shock. Diltiazem would worsen this condition by further reducing cardiac contractility and blood pressure. This is a critical 'SAFETY STOP'."
          },
          {
            "content": "administer the diltiazem as prescribed",
            "isCorrect": false,
            "justification": "Incorrect and dangerous. Administering diltiazem to a patient in potential cardiogenic shock is contraindicated and could lead to cardiovascular collapse. The nurse must recognize the signs of decompensation and withhold the medication. This could cause further hemodynamic instability."
          },
          {
            "content": "request an order for an IV fluid bolus",
            "isCorrect": false,
            "justification": "Incorrect as the first action. While fluid resuscitation might be considered, the client has a history of HFpEF and CKD, making them susceptible to fluid overload. Addressing the immediate risk of administering a contraindicated medication takes priority. The hyperkalemia also needs to be addressed urgently."
          },
          {
            "content": "start the heparin infusion immediately",
            "isCorrect": false,
            "justification": "Incorrect. While anticoagulation is important for atrial fibrillation, stabilizing the client's hemodynamic status and addressing the life-threatening hyperkalemia are the immediate priorities. Heparin does not address the impending cardiovascular collapse."
          }
        ]
      },
      {
        "label": "2",
        "choices": [
          {
            "content": "notify the provider of the critical findings",
            "isCorrect": true,
            "justification": "Correct. After ensuring patient safety by withholding the harmful medication, the nurse must immediately communicate the critical assessment data (hypotension, shock signs, critical hyperkalemia) to the provider to facilitate a new, appropriate plan of care. This includes SBAR communication to ensure clear and concise information transfer."
          },
          {
            "content": "prepare the client for synchronized cardioversion",
            "isCorrect": false,
            "justification": "Incorrect as the immediate independent nursing action. While cardioversion is likely the next treatment, it requires a provider order. The nurse's priority is to communicate the critical data that would prompt this change in plan. Also, hyperkalemia should be addressed prior to or concurrently with cardioversion if possible to reduce the risk of post-cardioversion arrhythmias."
          },
          {
            "content": "increase oxygen to 6L via simple face mask",
            "isCorrect": false,
            "justification": "Incorrect as the priority action. While the client is hypoxic, the root cause is poor perfusion (shock), not primary respiratory failure. Increasing oxygen is a supportive measure but does not take priority over communicating the life-threatening situation to the provider to correct the underlying cause. The underlying cause of the hypoxemia needs to be addressed."
          },
          {
            "content": "administer prescribed IV furosemide",
            "isCorrect": false,
            "justification": "Incorrect and potentially harmful. There is no order for furosemide. Furthermore, administering a diuretic to a patient who is hypotensive and in shock could worsen their intravascular volume depletion and blood pressure, exacerbating the shock state. This could worsen renal perfusion in the setting of CKD."
          }
        ]
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Evaluating",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Physiological Adaptation",
    "nclexSubCategory": "Hemodynamic Instability",
    "difficulty": "Level 5",
    "topicTags": [
      "Atrial Fibrillation",
      "Cardiogenic Shock",
      "Hyperkalemia",
      "Medication Safety",
      "Contraindication",
      "Hemodynamic Instability",
      "Chronic Kidney Disease"
    ]
  },
  "clinicalPearls": "*   **SBAR Communication:** When communicating with the provider, use the SBAR (Situation, Background, Assessment, Recommendation) format. For example: 'Situation: 78-year-old male with AFib RVR, now hypotensive and showing signs of shock. Background: History of CKD Stage 3 and HFpEF. Assessment: BP 84/52, HR 166, Lactate 4.5, Potassium 6.9. Recommendation: I held the diltiazem due to hypotension and recommend immediate intervention for hyperkalemia and hemodynamic support.'\n*   **Hyperkalemia Management:** Be prepared to administer medications like calcium gluconate, insulin/dextrose, and sodium polystyrene sulfonate (Kayexalate) as ordered to address the hyperkalemia.\n*   **Cardiogenic Shock:** Recognize the signs of cardiogenic shock (hypotension, altered mental status, cool/clammy skin, elevated lactate) and understand the importance of avoiding medications that further depress cardiac function.\n*   **Medication Contraindications:** Always review medication contraindications, especially in patients with multiple comorbidities and complex presentations.",
  "sentinelStatus": "healed_v2026_v8"
}